On April 1, 2025, the fee for filing a Certificate of Supplementary Protection (CSP) will increase by 2% from $10,356 to $10,564 in accordance with subsection 9(1) of the Certificate of Supplementary Protection Regulations (Canada Gazette notice).
Should you have any questions, please do not hesitate to contact a member of the Life Sciences Regulatory & Compliance Group.
The preceding is intended as a timely update on Canadian intellectual property and life sciences regulatory law. The content is informational only and does not constitute legal or professional advice. To obtain such advice, please communicate with our offices directly.
Related Publications & Articles
-
PMPRB published Meds Pipeline Monitor
On November 5, 2024, the Patented Medicine Prices Review Board (PMPRB) released the latest edition of Meds Pipeline Monitor, an annual report that reviews new medicines undergoing clinical evaluation ...Read More -
FCA sets aside PMPRB’s order that Galderma’s patent claiming 0.3% adapalene “pertained to” 0.1% adapalene DIFFERIN
On December 3, 2024, the Federal Court of Appeal (FCA) set aside the order of the Patented Medicine Prices Review Board (PMPRB or Board) that had required Galderma to continue to provide information t...Read More -
PMPRB releases 2023 Annual Report
On December 6, 2024, the Minister of Health tabled the 2023 Annual Report of the Patented Medicine Prices Review Board (PMPRB).Read More